Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.3K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

998
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
998
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Retroviruses02:33

Retroviruses

15.6K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.

Methods in molecular biology (Clifton, N.J.)·2018
Same author

Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.

The journal of gene medicine·2018
Same author

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Blood advances·2018
Same author

Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.

Oncotarget·2018
Same author

Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.

Biomedicines·2017
Same author

Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy.

Biomedicines·2017

Related Experiment Video

Updated: Mar 16, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

11.3K

Retroviral vector interactions with hematopoietic cells.

Elizabeth M Everson1, Grant D Trobridge2

  • 1Department of Pharmaceutical Sciences, Washington State University, Spokane, WA 99210, United States.

Current Opinion in Virology
|August 14, 2016
PubMed
Summary

Hematopoietic stem cell gene therapy offers permanent correction for blood disorders. Advances in retroviral vectors improve safety and efficiency for treating quiescent stem cells.

More Related Videos

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

8.9K
Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

20.2K

Related Experiment Videos

Last Updated: Mar 16, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

11.3K
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

8.9K
Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

20.2K

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Hematology

Background:

  • Hematopoietic stem cell (HSC) gene therapy shows promise for correcting genetic blood disorders.
  • Key challenges include efficiently transducing quiescent HSCs and minimizing genotoxicity.

Purpose of the Study:

  • This review focuses on recent advancements in retroviral vector technology for HSC gene therapy.
  • The goal is to enhance transduction efficiency, control transgene expression, and improve safety.

Main Methods:

  • Review of recent literature on retroviral vector modifications.
  • Analysis of strategies to improve vector entry and transduction of HSCs.
  • Examination of methods for controlling transgene expression and altering integration profiles.

Main Results:

  • Retroviral vectors (lentiviral, foamy) have been significantly modified for better safety and efficacy.
  • New approaches enhance vector entry and transduction of quiescent HSCs.
  • Strategies are emerging to control transgene expression and reduce genotoxicity via integration modification.

Conclusions:

  • Ongoing research in retroviral vector design is crucial for advancing HSC gene therapy.
  • Improved vector systems offer greater potential for safe and effective treatment of hematopoietic disorders.
  • Future directions involve optimizing vector delivery, expression, and integration for clinical application.